U.S. market Closed. Opens in 1 day 5 hours 20 minutes

ITOS | iTeos Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue12.60M267.63M344.77MN/AN/AN/A
Cost of Revenue898.00K813.00K615.00K535.00K611.00K505.00K
Gross Profit11.70M266.82M344.16M-535.00K-611.00K-505.00K
Operating Expenses163.70M138.04M89.69M39.31M23.27M17.82M
Selling, General & Admin50.40M43.95M40.51M15.34M8.84M4.31M
Research & Development113.30M97.36M59.37M29.90M19.21M17.19M
Other Operating ExpensesN/A-3.26M-10.18M-5.93M-4.78M-163.00K
Operating Income-151.10M126.32M244.90M-45.24M-28.05M-21.50M
Other Expenses / Income42.07M22.41M11.56M7.15M5.71M3.46M
Before Tax Income-109.03M148.74M256.46M-38.09M-22.34M-18.05M
Income Tax Expenses3.61M52.08M41.94M-57.00K119.00K11.00K
Net Income-112.64M96.65M214.52M-38.03M-22.45M-18.06M
Interest ExpensesN/AN/AN/AN/AN/A66.00K
Basic Shares Outstanding35.76M35.55M35.18M35.04M35.02M7.51M
Diluted Shares Outstanding35.76M37.77M37.77M35.04M35.02M7.51M
EBITDA-151.10M148.38M257.08M-37.84M-21.72M-17.48M
EBITDA Margin-1,199.69%55.44%74.56%0.00%0.00%0.00%
EBIT-109.03M148.74M256.46M-38.09M-22.34M-17.98M
EBIT Margin-865.66%55.58%74.39%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙